Halozyme Therapeutics shares owned by Shenkman Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Shenkman Capital Management
from 13F filings
Historical chart of Shenkman Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Shenkman Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $24B | 23M | 1013.38 |
| 2024-06-30 | $17B | 17M | 969.41 |
| 2024-03-31 | $7.6B | 8.4M | 912.89 |
| 2023-12-31 | $7.0B | 8.0M | 880.50 |
| 2023-09-30 | $7.8B | 9.0M | 861.26 |
| 2023-06-30 | $7.2B | 8.6M | 830.82 |
| 2023-03-31 | $7.6B | 8.9M | 848.72 |
| 2022-12-31 | $12B | 12M | 966.65 |
| 2022-09-30 | $7.0M | 8.3M | 0.85 |
| 2022-06-30 | $6.9M | 7.9M | 0.88 |
More positions owned by Shenkman Capital Management
View all positions for Shenkman Capital Management